United States · How much has Voltron Therapeutics raised?
Voltron Therapeutics has raised $5.9M across 1 round since 2023.
United States · Funded startup
Who invested in Voltron Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Voltron Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$5.9Mraised across 1 round since 2023, from 1 source
- Latest round
- Grant, $5.9MAug 2023
- Investors
- 0
The rounds
- Aug 2023Grant$5.9M
No investor was named in the report.
Source recordedSEC filing: $3.2M sold, first sale Oct 2022
Funding filed with regulators
Voltron Therapeutics filed 4 raises, $9.4M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Oct 2022$3.2MSEC Form D
- Jun 2022$300KSEC Form D
- Aug 2021$2.5MSEC Form D
- Oct 2019$3.3MSEC Form D
Founders and team
From the SEC filings it signed: 2 on the team.
- Patrick GallagherChief Executive Officeri
- Matthew DuffyPresidenti
On the board, as filediAnthony ZookJames AhernMatthew EitnerPaul Korner
Quick answers about Voltron Therapeutics
When did Voltron Therapeutics last raise?
Voltron Therapeutics's most recent round was a Grant of $5.9M in Aug 2023.
What was Voltron Therapeutics's biggest round?
Its most recent round, $5.9M in Aug 2023, is also its largest on record.
What stage is Voltron Therapeutics at?
Voltron Therapeutics's latest named round is a Grant, in Aug 2023.
Where is Voltron Therapeutics based?
Voltron Therapeutics is based in the United States.
Companies like Voltron Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.